Published peptide research references
Ulimorelin
Governed registry record
3 approved source records with original-source links. Source verification confirms the reference and its connection to this record; it does not certify every scientific conclusion or establish safety or efficacy.
Approved source records
A multicenter, randomized, double-blind study of ulimorelin and metoclopramide in the treatment of critically ill patients with enteral feeding intolerance: PROMOTE trial.
DOI: 10.1007/s00134-019-05593-2
Source identity and connection checked by Codex (AI).
Optimization of the potency and pharmacokinetic properties of a macrocyclic ghrelin receptor agonist (Part I): Development of ulimorelin (TZP-101) from hit to clinic.
Source identity and connection checked by Codex (AI).
Safety and efficacy of ulimorelin administered postoperatively to accelerate recovery of gastrointestinal motility following partial bowel resection: results of two randomized, placebo-controlled phase 3 trials.
DOI: 10.1097/dcr.0b013e31829196d0PMID: 23739196
Source identity and connection checked by Codex (AI).
Legacy research context
Context from the legacy curated dataset. Its counts describe that dataset and are separate from the live approved source records above.
Researchers represented
- James J
- Mair S
- Doll W
- Sandefer E
- Wurtman D
- Maurer A
- Deane AM
- Harris MS
- Heyland DK
- van Zanten ARH
- Grau-Carmona T
- Evans D
- Beishuizen A
- Schouten J
- Hoiting O
- Bordejé ML
- Krell K
- Klein DJ
- Gonzalez J
- Perez A
- Brown R
- Investigators of the PROMOTE LP101-CL-201 Trial
- Shaw M
- Pediconi C
- McVey D
- Mondou E
- Quinn J
- Chamblin B
- Rousseau F
- Hoveyda HR
- Marsault E
- Gagnon R
- Mathieu AP
- Vézina M
- Landry A
- Wang Z
- Benakli K
- Beaubien S
- Saint-Louis C
- Brassard M
- Pinault JF
- Ouellet L
- Bhat S
- Ramaseshan M
- Peng X
- Foucher L
- Beauchemin S
- Bhérer P
- Veber DF
- Peterson ML
- Fraser GL